Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)

Summary

This research study is a Phase II clinical trial. Phase II clinical trials test the effectiveness of an investigational combination of drugs. The purpose is to learn whether the combination of drugs works in treating a specific cancer. "Investigational" means that the combination of drugs is still being studied. It also means that research doctors are trying to find out more about it. Examples of what they want to learn about are the safest dose to use, the side effects it may cause, and if the combination of drugs works for treating different types of cancer.

Timeline

Start

2013-03

Primary completion

2016-12

Completion

2017-12

Drugs

Indications